| Previous Close | 1.4500 |
| Open | 1.4500 |
| Bid | 1.4000 x 0 |
| Ask | 1.4400 x 0 |
| Day's Range | 1.4100 - 1.4500 |
| 52 Week Range | 0.8600 - 1.5000 |
| Volume | 21,202 |
| Avg. Volume | 43,195 |
| Market Cap | 199.028M |
| Beta (5Y Monthly) | 1.23 |
| PE Ratio (TTM) | 240.00 |
| EPS (TTM) | 0.0060 |
| Earnings Date | Aug. 20, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.00 |
- Simply Wall St.
Will Hamilton Thorne (CVE:HTL) Multiply In Value Going Forward?
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst...
- GlobeNewswire
Hamilton Thorne to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
BEVERLY, Mass. and TORONTO, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that David Wolf, President and CEO of Hamilton Thorne Ltd., will deliver a virtual presentation at the upcoming H.C. Wainwright 22nd Annual Global Investment Conference on Tuesday, September 15, 2020 at 2:30 pm EDT. Mr. Wolf will also be available for virtual one-on-one meetings during the conference. About Hamilton Thorne Ltd. (www.hamiltonthorne.ltd)Hamilton Thorne is a leading global provider of precision instruments, consumables, software and services that reduce cost, increase productivity, improve results and enable breakthroughs in Assisted Reproductive Technologies (ART), research, and cell biology markets. Hamilton Thorne markets its products and services under the Hamilton Thorne, Gynemed, Planer, and Embryotech Laboratories brands, through its growing sales force and distributors worldwide. Hamilton Thorne’s customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments.Neither the TSX Venture Exchange, nor its regulation services provider (as that term is defined in the policies of the exchange), accepts responsibility for the adequacy or accuracy of this release.For more information, please contact: David Wolf, President & CEOMichael Bruns, CFOGlen Akselrod Hamilton Thorne Ltd.Hamilton Thorne Ltd.Bristol Investor Relations 978-921-2050978-921-2050905-326-1888 ir@hamiltonthorne.ltd ir@hamiltonthorne.ltd glen@bristolir.com
- The Motley Fool
Will the TSX Stock Market Crash Again?
If TSX was overpriced before the pandemic, and many stocks have regained their pre-pandemic values, it indicates that the market is ripe for another crash.The post Will the TSX Stock Market Crash Again? appeared first on The Motley Fool Canada.
